The melting point of lidocaine was significantly lowered when mixed with th
ymol and/or aqueous ethanol. Mixtures of lidocaine and thymol at ratios wit
hin the range of 30:70-70:30 (w:w) became homogeneous oils at 25 degreesC.
In a pH 9.2 carbonate buffer containing 25% ethanol, lidocaine (5%, w:w) al
so liquefied at 25 degreesC. The studies led to the development of novel tw
o-phase melt systems of lidocaine (TMS) which consisted of a highly concent
rated oil phase of lidocaine and an alcoholic aqueous phase. A compositiona
l phase diagram showed that in aqueous dispersions of lidocaine, concurrent
use of thymol and ethanol depressed the melting point of lidocaine more ef
fectively than when they were used individually. Both thymol and aqueous et
hanol were necessary as melting point depressing agents to achieve the high
est possible lidocaine concentration of 87% (w:w) in the oil phase of a TMS
at 25 degreesC. Containing an internal oil phase and an external aqueous p
hase at ambient temperature, such a TMS can be readily formulated into topi
cal O/W cream after addition of proper surfactants and thickening agents. I
n an anesthetic activity lest using mouse tail-flick model, a 5% lidocaine
cream prepared was highly effective as shown by the prolonged latency time
of the mice to a heat stimulus as compared with a placebo (P <0.05). (C) 20
01 Elsevier Science B.V. All rights reserved.